Mirae Asset Healthcare Fund - IDCW - Direct Plan

Other Plans and Options
  • 1.68 %Nav, as on 13-08-2025

  • Previous Nav

  • Net Change on 13-08-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview IDCW | Direct Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India. The Scheme does not guarantee or assure any returns.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
Mirae Asset Healthcare Fund Direct IDCW -1.04 6.86 5.29 22.67 20.15 22.62
BSE Health Care - TRI N/A N/A N/A N/A N/A N/A
BSE SENSEX - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Mirae Asset Healthcare Fund Direct IDCW Jul 02, 2018 5.29 22.67 20.15 0.48 2,908.21
NIPPON INDIA PHARMA FUND - DIRECT Plan - IDCW Option Jan 01, 2013 2.91 23.30 19.29 0.89 8,736.57
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - IDCW Option Jul 13, 2018 9.45 28.39 22.07 1.04 6,103.96
SBI Healthcare Opportunities Fund - Direct Plan - Income Distribution cum Capital Withdrawal Option (IDCW) Jan 01, 2013 11.51 27.64 21.28 0.91 4,026.55
TATA India Pharma & Health Care Fund Direct Plan - Payout of Income Distribution cum capital withdrawal option Dec 28, 2015 4.88 24.98 20.33 0.61 1,339
TATA India Pharma & Healthcare Fund Direct Plan - Reinvestment of Income Distribution cum capital withdrawal option Dec 28, 2015 4.88 24.98 20.33 0.61 1,339

Fund Holdings as on 31-July-2025

  • Sun Pharmaceutical Industries Ltd.

  • Divi's Laboratories Ltd.

  • Glenmark Pharmaceuticals Ltd.

  • Aurobindo Pharma Ltd.

  • Cipla Ltd.

  • Apollo Hospitals Enterprise Ltd.

  • Lupin Ltd.

  • Dr. Reddy's Laboratories Ltd.

  • Krishna Institute of Medical Sciences Ltd.

  • Cohance Lifesciences Ltd.

  • Fortis Healthcare Ltd.

  • IPCA Laboratories Ltd.

  • Aster DM Healthcare Ltd.

  • Torrent Pharmaceuticals Ltd.

  • JB Chemicals & Pharmaceuticals Ltd.

  • Onesource Specialty Pharma Ltd.

  • Alkem Laboratories Ltd.

  • Gland Pharma Ltd.

  • Eris Lifesciences Ltd.

  • Wockhardt Ltd.

  • Laurus Labs Ltd.

  • Mankind Pharma Ltd.

  • Sai Life Sciences Ltd.

  • Anthem Biosciences Ltd.

  • Biocon Ltd.

  • Alembic Pharmaceuticals Ltd.

  • Sagility India Ltd.

  • Deepak Nitrite Ltd.

  • Laxmi Dental Ltd.

  • Syngene International Ltd.

  • Neogen Chemicals Ltd.

  • TREPS

  • Mirae Asset Liquid Fund-Direct Plan-Growth

  • Net Receivables / (Payables)

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Business Support

  • Chemicals

  • Medical Equipment/Supplies/Accessories

  • Miscellaneous

View More

Fund Manager

  • Education:B.Com & C.A.
  • Experience:12
  • Basic Details:Mr. Tanmay Mehta has over 12 years of experience primarily into equity research. He has been associated with the AMC since Jan 2021. Prior to this, Mr. Mehta has worked across Institutional Equity Research and Investment Banking Functions at SBI Capital Markets. He is a Chartered Accountant and has also cleared CFA (US).
  • Funds Managed:
  • Mirae Asset Healthcare Fund
  • Mirae Asset Healthcare Fund

Most Recent Dividend

  • 26/03/2025

  • 26/03/2024

  • 15/02/2023

  • 28/10/2022

  • 23/03/2022

  • Cash

  • Equity

  • MFU

View More

About Mirae Asset Healthcare Fund

Scheme Analysis

Mirae Asset Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to Mirae Asset Mutual Fund. It was launched on 02-Jul-2018 and currently has an AUM of ₹2,908.21 crore. Mirae Asset Healthcare Fund is benchmarked against BSE Health Care - TRI as primary index and BSE SENSEX - TRI as secondary index.

The NAV of Mirae Asset Healthcare Fund ended up ₹0.47(1.68%)yesterday to ₹28.552.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Ltd., and

The Mirae Asset Healthcare Fund is managed by Vrijesh Kasera and Tanmay Mehta.

Fund House Contact

Unit 606, 6th Floor, Windsor Building, Off CST Road, Kalina, Santacruz (E), Mumbai - 400 098

022-67800300
022-67253940